Wacker Buys Silicone Production Plant in South Korea

Wacker Chemie AG subsidiary Wacker Chemicals Korea is acquiring the Lucky Silicone brand from Henkel Technologies (Korea) Ltd. The two companies announced a purchase agreement, effective on Thursday. The transaction still requires antitrust approval.

As part of the acquisition, Wacker takes over not only the rights to this South Korean brand, but also the production plant in Jincheon (some 100 km south-east of Seoul), including the associated real estate. Additionally, Wacker will assume all the inventories and receivables related to this business. The Munich-based chemical company intends to keep on the site's existing workforce of some 40 employees. The transaction's closing is expected before year-end 2010. The Lucky Silicone brand mainly comprises silicone sealants, manufactured and marketed for use in construction and other industries. Last year, Henkel Technologies Korea generated sales of roughly €20 million with Lucky Silicone products.

Company

Wacker Chemie

Hanns-Seidel-Platz 4
81737 Munich
Germany

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.